AstraZeneca's CFO Simon Lowth leaves for BG Group

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here each Friday.

AstraZeneca's CFO Simon Lowth leaves for BG Group

Simon Lowth, CFO at AstraZeneca ($AZN), left the company for the same position at BG Group. According to Reuters, Lowth jumped ship after being passed over for the top position at the drugmaker, which went with Pascal Soriot as its CEO in October last year. Reuters also notes that Lowth "is leaving one company faced with a turbulent financial future for another." Article | More

AstraZeneca/BG Group
Simon Lowth leaves AstraZeneca for BG Group CFO position.

WuXi PharmaTech/PRA
WuXi and PRA picked up James Pusey as president and general manager.

Biotech

Gordon K. Johnson joined KemPharm as the company's chief operating officer and chief financial officer. Release

SciClone Pharmaceuticals ($SCLN) appointed Wilson W. Cheung as chief financial officer and senior vice president of finance. Prior to SciClone, Cheung served as chief compliance officer at Velti. Release

DNAnexus brought on Omar Serang as the company's chief cloud officer. DNAnexus specializes in cloud-based DNA data management and analysis solutions. Release

Henrik Juuel joined Orexo as chief financial officer, leading the company's effort to commercialize its FDA-approved lead product, Zubzolv. Release

Intarcia Therapeutics snagged Eddie Li to be the vice president and global head of regulatory affairs. Previously, Li served as vice president and head of U.S. regulatory affairs at Novo Nordisk ($NVO). Release

Gaston L. Bernstein joined Biomed Pharmaceuticals as the company's new CEO. Release

> Biovest International has emerged from bankruptcy and has promoted Carlos F. Santos as CEO. Biovest's former CEO, Samuel S. Duffey, will lead a new Biovest-owned subsidiary. Release

Oligomerix has appointed James Hendrix as senior director of chemistry. Previously, Hendrix spent most of his 20-year career at Sanofi-Aventis. Release

CytomX Therapeutics has appointed Dr. Krishna Polu to the newly created position of chief medical officer. Prior to joining CytomX, Polu served as vice president, clinical development at Affymax ($AFFY). CytomX also promoted Debanjan Ray to the role of vice president, business development and alliance management. Ray joined CytomX in August 2011 as senior director, head of business development. Release

General George A. Joulwan has joined Emergent BioSolutions' ($EBS) board of directors. Release

Hyperion Therapeutics ($HPTX) has added three new executives to its leadership team: Ashley Gould as senior vice president, governmental affairs and chief legal officer; Natalie Holles as senior vice president, corporate and business development; and Sylvia Wheeler, vice president, investor relations and corporate communications. Release

Dr. Sarah J. Schlesinger, senior attending physician and associate professor of clinical investigation in the Laboratory of Cellular Physiology and Immunology at The Rockefeller University, has joined the board of ARIAD Pharmaceuticals ($ARIA). Release

Dr. Marshall Urist has joined Royalty Pharma as vice president, Research and Investments. Urist spent the last 8 years at Morgan Stanley in equity research, most recently as executive director and the senior biotechnology analyst. Release

Pharma

Visterra brought on Dr. Brian Pereira as the company's new CEO. Before Visterra, Pereira was president and CEO of Amag Pharmaceuticals ($AMAG). Release

BioSante Pharmaceuticals ($BPAX) has hired Robert Schrepfer as vice president of new business development and contract manufacturing. Previously, Schrepfer was vice president, equity research, covering the major and specialty pharmaceuticals sector at Bear Stearns. Release

CRO

Dr. James Pusey has joined WuXiPRA as president and general manager. Prior to joining WuXiPRA, Pusey was founding CEO of Theorem Clinical Research, where he served as president and chief executive officer, executive chairman, and board director from 2009 through 2013. Story

Alison Taber and Jeff Wiley have joined Theorem Clinical Research as vice president of global data management and senior director of clinical operations, respectively. Release

Richard Koenig is joining Rho as vice president of operations. Koenig's most recent position was vice president, operations for ClinStar, located in Durham, NC. Release

Frontage Laboratories has appointed Dr. Cheryl Li as senior vice president of Global CMC Services. Previously, Li held several management positions at Johnson & Johnson ($JNJ) Consumer Group companies. Release

Clinipace Worldwide has added Mark Ubert as chief financial officer. Ubert previously held positions at Ernst & Young and KPMG. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.